SA

Samsara

Boston, US · 3 known investors

samsaratherapeutics.com ↗

Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease. It runs an in-house phenotypic screening platform using patient-derived iPSCs to identify and validate autophagy activators for drug discovery.

Investors · 3

AP

Apollo Health Ventures✓ verifiedBerlin

CO

CoastCapVienna

KO

Korify Capital